Oct. 24 at 10:05 PM
$ZBH ZBH US Zimmer Biomet dominates musculoskeletal healthcare globally. Revenue surges to
$7.83B TTM with operating profit soaring past
$1.5B. EPS beats forecasts. The stock is a hidden gem with a forward P/E of only 12.1, severely undervalued. Massive growth and reliable dividends.